We report the results of a three-dimensional quantitative structure-activity relationship (3D-QSAR)/ comparative molecular field analysis (CoMFA) of the activity of 18 bisphosphonates and imidodiphosphate in the inhibition of a mung bean (Vigna radiata L.) vacuolar proton pumping pyrophosphatase (V/H ؉ -PPase; EC 3.6.1.1). We find an experimental versus QSAR predicted pK i app R 2 value of 0.89, a crossvalidated R 2 ‫؍‬ 0.77, and a bootstrapped R 2 ‫؍‬ 0.89 for 18 bisphosphonates plus imidodiphosphate over the 1.3 M to 425 M range of K i app values. We also demonstrate that this approach has predictive utility (a 0.26 pK i app rms error for three test sets of 3 activity predictions each), corresponding to about a factor of two error in K i app prediction. The 3D-QSAR/CoMFA approach provides a quantitative method for predicting the activity of V/H ؉ -PPase inhibitors and is likely to be of use in the design of novel pharmacological agents since all of the major human disease-causing parasitic protozoa contain large levels of pyrophosphate, together with V-type proton-pumping pyrophosphatases located in plant-like vacuoles (acidocalcisomes), which are absent in their mammalian hosts.
In recent work (1-4) using nuclear magnetic resonance spectroscopy we found evidence for the presence of high levels of pyrophosphate (diphosphate) in many of the major human disease-causing parasitic protozoa: Trypanosoma cruzi (1), Trypanosoma brucei (2), Leishmania major (2) , Toxoplasma gondii (3, 4) , Plasmodium falciparum (4) and Cryptosporidium parvum (4) . These organisms are, respectively, the causative agents of Chagas' disease, human African sleeping sickness, visceral leishmaniasis, toxoplasmosis, malaria and cryptosporidiosis. These diseases afflict hundreds of millions of individuals in less developed nations as well as cause opportunistic infections in the immuno-compromised worldwide. The observation of large levels of PP i led to the discovery (1, 2) of its primary localization in the acidocalcisome (5) , an acidic vacuole present in each of the parasites. This then led to the discovery of plant-like (6) proton-pumping vacuolar pyrophosphatases in many disease-causing protozoa (7) (8) (9) (10) . In earlier work (11, 12) , it was found that some pyrophosphate analogs, bisphosphonates (containing a non-hydrolysable P-C-P, rather than a P-O-P, backbone) as well as imidodiphosphate (containing a non-hydrolysable P-N-P group), were inhibitors of a plant (mung bean, Vigna radiata L.) V/H ϩ -PPase, and more recently Gordon-Weeks et al. reported a more extensive investigation of the structural aspects of the effectiveness of bisphosphonates as competitive inhibitors of the same enzyme (13) . Several of these compounds have also been found to have inhibitory activity against the parasite enzymes (7-10). Given the potential importance of the V/H ϩ -PPase in parasite cell growth and since it is absent from human host cells, the plant results take on increased significance since they may help to facilitate the design of novel antiparasitic drugs. However, all of the reports to date discuss only qualitative structure-activity relationships. Here, we report the first quantitative structureactivity relationship (3D-QSAR) investigation, using a comparative molecular field analysis (CoMFA), of the inhibition of the V. radiata V/H ϩ -PPase by 18 bisphosphonates and by imidodiphosphate. In particular, we show that the activities of the V/H ϩ -PPase inhibitors can be predicted to within about a factor of two. In addition, the CoMFA results emphasize the overwhelming importance of electrostatic interactions between the bisphosphonates and the V/H ϩ -PPase.
MATERIALS AND METHODS
3D-QSAR/CoMFA. CoMFA was performed within the QSAR module of Cerius2 4.5 using default settings (14). Molecular mechan-ics calculations for geometry optimization were performed by using a universal molecular mechanics force field (UFF), with a convergence criterion requiring a minimum energy change of 0.001 kcal/mol. Charge calculations were performed by using the Gasteiger method (15) . The CoMFA calculated probe interaction energies on a rectangular grid around the surface of the aligned molecules. The atomic coordinates of the models were used to compute field values at each point on a 3D grid whose spacing was adjusted to 1.00 Å. CoMFA evaluated the energy between probes (H ϩ , CH 3 , and hydrogen bond donor/acceptor) and a given inhibitor at a series of points defined by the rectangular grid. In a first set of calculations, we used 18 bisphosphonates plus imidodiphosphate to evaluate the QSAR of V. radiata V/H ϩ -PPase inhibitors. Then, to better estimate predictive ability we used three reduced training sets, each containing 16 compounds, to predict the activities of three test sets, each containing 3 compounds, as discussed in detail below.
RESULTS AND DISCUSSION
We show in Fig. 1 Table 1 (12, 13) . Bisphosphonate structures were generated for CoMFA investigation by using steepest descents followed by conjugate gradient, then Newton-Raphson, algorithms for geometry optimization, with no constraints on the internal geometry of the molecules, using the Minimizer function of the OFF Methods module in Cerius2 4.5 (14). Each molecule was aligned to the most active molecule (aminomethylene bisphosphonate, AMBP) acting as a template by performing an rms-fitting of the pharmacophoric atoms of each conformer to those of the template by using the shape reference alignment function of the QSAR module of Cerius2 4.5. The alignments of each structure, obtained through pairwise BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS superpositioning using the maximum common subgroup (MCSG) method, placed all 19 structures in the study table in the same reference frame as the shape reference compound. After visual inspection, the alignment was further refined by matching the P-C-P atoms of compound 10 and the P-N-P atoms of imidodiphosphate to the P-C-P atoms in AMBP (reference model) by an rms-fitting atom-matching algorithm in the Cerius2 4.5 software program. The aligned set of structures is shown in Fig. 2 . For the aromatic species, the ring nitrogens were singly protonated while the aminoalkyl species had ammonium groups present. Monoprotonated phosphonate groups [P(O) 2 (OH)] Ϫ1 were used throughout. We then used CoMFA 3D-QSAR methodologies, as embodied in the Cerius2 4.5 suite of programs, to analyze the inhibition data shown in Table 1 using the relationship pK i app ϭ Ϫlog 10 (K i app , M). We performed a regression analysis of the inhibition results by using a genetic function approximation (GFA) algorithm (16) to obtain the following QSAR equation:
where the descriptor, H ϩ , defines the corresponding probe interaction energy between a proton and the molecule of interest, at specified grid points. The locations of the descriptors in Eq. 1 are shown in Fig. 2 . The optimal number of components in the final GFA model was determined by cross-validated R 2 and standard error prediction values, as obtained from the leave-oneout cross-validation technique. The GFA analysis gave a correlation coefficient of 0.89, with a cross-validated R cv 2 of 0.77, and an optimal number of components of 5. To obtain statistical confidence limits, the non-cross- validated analysis was repeated with 10 bootstrap groups, which yielded an R bs 2 of 0.89. These statistical parameters are given in Table 1 . Cross-validation provides information concerning the predictive ability of the QSAR data set by minimizing the occurrence of chance correlations in the QSAR model, and the bootstrapped R bs 2 value of 0.89 indicates a good degree of confidence in the analysis. Experimental and predicted pK i app values are shown in Table 1 and Fig. 3A . These results were of interest since they implied that it might be possible to predict K i app values for V. radiata V/H ϩ -PPase inhibition. The experimental range of activity (K i app ) varies from 1.32 M for AMBP to 425 M for bisphosphonate 5, as listed in Table 1 . However, the R 2 values obtained from the results shown in Fig. 3A were lower than might typically be obtained for a larger training set and of course there may be additional uncertainties introduced by use of an intact tonoplast assay (as opposed to the use of a purified enzyme). Therefore, in order to better test the predictive ability of this 3D-QSAR/CoMFA model of V/H ϩ -PPase inhibition, we carried out three additional sets of calculations in which we deleted at random three (test set) points from the training set. The QSAR equations were then recomputed, the results of which were used to calculate the pK i app values for the three compounds in each test set (Table 1, bold) .
The QSAR equations from the three reduced training sets were:
pK i app ϭ 4.308 ϩ 0.054 ‫ء‬ "H ϩ /78"
The three sets of predicted pK i app values are shown in bold in Table 1 Figs. 3B-3D ) and the experimentally observed values with an rms error of 0.26, corresponding to an R 2 value of 0.80. The predictions of the activities of those compounds in the training sets are also shown (Table 1 , E in Figs. 3B-3D ). These results strongly suggest, therefore, that it is now possible to predict the pK i app values for V/H ϩ -PPase inhibition by these bisphosphonates and by imidodiphosphate to within about a factor of two (rmsd ϭ 0.26). Based on the QSAR/CoMFA results (Eqs. [1] [2] [3] [4] , it is also apparent that the competitive inhibition of V/H ϩ -PPase by the bisphosphonates studied is overwhelmingly electrostatic in nature.
These QSAR results are to be compared with bisphosphonate inhibition of two other enzymes: farnesyl diphosphate synthase (FPPSase) and geranylgeranyl diphosphate synthase (GGPPase) (17) (18) (19) . In the case of pamidronate and alendronate (Fig. 1) , both molecules are Ϸ0.5 M inhibitors of FPPSase. This is much lower than the ϳ10 -30 M values seen in V/H ϩ -PPase inhibition (Table 1) , but in both enzymes the CoMFA results indicate that primarily electrostatic interactions dominate. In the case of FPPSase, it is thought that the potent nitrogen-containing bisphosphonates used in bone resorption therapy, which also have considerable activity against parasitic protozoa, act as carbocation transition state/reactive intermediate analogs (20) . There are thus strong interactions between both the phosphonate headgroups and the ammonium (pyridinium) side-chains with FPPSase. With GGPPSase, however, hydrophobic interactions between the long alkyl/alkenyl sidechains of bisphosphonate inhibitors and the protein are very important (19) and the QSAR model is dominated by such steric/ hydrophobic interactions. In the case of the V/H ϩ -PPase, however, hydrophobic interactions (manifest as contributions of CH 3 probe interaction energies to the calculated activity) are very small and indeed need not be incorporated into the QSAR model at all, as shown in Eqs. 1-4. Thus, bisphosphonates clearly inhibit different enzymes in quite different ways, through various types of interactions, ranging from overwhelmingly electrostatic with the V/H ϩ -PPase, to mixed electrostatic/H-bonding/steric with FPPSase, to primarily steric or hydrophobic with GPPSase (17) (18) (19) .
In conclusion then, the results we have shown above are of importance for several reasons. First, they represent the first QSAR analysis of the inhibition of a vacuolar, proton-pumping pyrophosphatase by imidodiphosphate and by a series of bisphosphonates. Second, the results obtained indicate that it is possible to predict the activity (pK i app ) of a broad range of V/H ϩ -PPase inhibitors with an rms error of 0.26, corresponding to an average K i app prediction error of about a factor of 2. Since all of the major human disease-producing protozoa possess this enzyme while their human hosts do not, V/H ϩ -PPase is a potentially attractive target for chemotherapeutic intervention and the results presented above indicate that it may now be possible to begin to use QSAR methods to develop improved inhibitors against both plant and parasite enzymes. Third, our QSAR results show the overwhelming dominance of purely electrostatic interactions in the bisphosphonate/imidodiphosphate V/H ϩ -PPase QSAR, unlike results recently obtained with these and related compounds acting as inhibitors of the prenyl synthases, FPPSase and GGPPSase (17) (18) (19) , in which donor/ acceptor and purely steric/hydrophobic/dispersive interactions become increasingly important, presumably due to the fact that the bisphosphonates mimic much larger carbocation species which are buried in the active sites of the FPP and GGPP synthases. Table 1 . The line represents the ideal slope of 1.
